Breaking Down Privia Health Gr: 5 Analysts Share Their Views
In the preceding three months, 5 analysts have released ratings for Privia Health Gr (NASDAQ:PRVA), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Privia Health Gr and provided 12-month price targets. The average target is $32.6, accompanied by a high estimate of $35.00 and a low estimate of $31.00. Observing a downward trend, the current average is 0.46% lower than the prior average price target of $32.75.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Privia Health Gr among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Daniel Grosslight | Citigroup | Lowers | Buy | $32.00 | $34.00 |
| Jailendra Singh | Truist Securities | Raises | Buy | $33.00 | $31.00 |
| Richard Close | Canaccord Genuity | Raises | Buy | $35.00 | $34.00 |
| Ryan Halsted | RBC Capital | Announces | Outperform | $31.00 | - |
| Jeff Garro | Stephens & Co. | Maintains | Overweight | $32.00 | $32.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Privia Health Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Privia Health Gr compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Privia Health Gr's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Privia Health Gr's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Privia Health Gr analyst ratings.
All You Need to Know About Privia Health Gr
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Understanding the Numbers: Privia Health Gr's Finances
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Privia Health Gr's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 32.54%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Privia Health Gr's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Privia Health Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.99%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Privia Health Gr's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.52%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
What Are Analyst Ratings?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.